These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1288158)

  • 21. [Non-ionogenic surface-active agents as a component of oxygen carrying fluorocarbon blood substitutes].
    Afonin NI; Rybolovleva IuR; Putiatina TK; Aprosin IuD; Doronina NN
    Probl Gematol Pereliv Krovi; 1982 Oct; 27(10):12-4. PubMed ID: 7178045
    [No Abstract]   [Full Text] [Related]  

  • 22. [Characteristics of the body oxygen supply when replacing blood loss of moderate severity with an emulsion of perfluoroorganic compounds and with polyglucin].
    Iarochkin VS; Volos OP; Koziner VB
    Gematol Transfuziol; 1986 Jun; 31(6):43-7. PubMed ID: 2426156
    [No Abstract]   [Full Text] [Related]  

  • 23. Perfluorocarbons as oxygen-transport fluids.
    Lowe KC
    Comp Biochem Physiol A Comp Physiol; 1987; 87(4):825-38. PubMed ID: 2887381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy.
    Riess JG; Dalfors JL; Hanna GK; Klein DH; Krafft MP; Pelura TJ; Schutt EG
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):839-42. PubMed ID: 1391519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Extrapulmonary fluorocarbon oxygenation].
    Moroz VV; Bobrovskiĭ RV
    Anesteziol Reanimatol; 1996; (5):20-3. PubMed ID: 9027248
    [No Abstract]   [Full Text] [Related]  

  • 26. [Kinetics of oxygen saturation of fluorocarbon emulsions].
    Aprosin IuD; Alekseeva VK; Afonin NI
    Vopr Med Khim; 1980; 26(6):793-9. PubMed ID: 7456409
    [No Abstract]   [Full Text] [Related]  

  • 27. Formulation of highly concentrated fluorocarbon emulsions and assessment by near-total exchange perfusion of the conscious rat.
    Arlen C; Follana R; Le Blanc M; Long C; Long D; Riess JG; Valla A
    Biomater Artif Cells Artif Organs; 1988; 16(1-3):455-7. PubMed ID: 3179483
    [No Abstract]   [Full Text] [Related]  

  • 28. Emulsions of perfluorochemicals as blood substitutes.
    Sloviter HA; Mukherji B
    Acta Anaesthesiol Belg; 1984; 35 Suppl():61-8. PubMed ID: 6516760
    [No Abstract]   [Full Text] [Related]  

  • 29. Perfluorochemical emulsions: potential clinical uses and new developments.
    Levine EM; Tremper KK
    Int Anesthesiol Clin; 1985; 23(1):211-30. PubMed ID: 3884515
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel fluorocarbon-based injectable oxygen-carrying formulations with long-term room-temperature storage stability.
    Riess JG; Cornelus C; Follana R; Krafft MP; Mahé AM; Postel M; Zarif L
    Adv Exp Med Biol; 1994; 345():227-34. PubMed ID: 8079712
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxygen-carrying blood substitutes.
    Messmer K
    Int Anesthesiol Clin; 1983; 21(2):137-54. PubMed ID: 6862655
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthetic oxygen transport fluids based on perfluorochemicals: applications in medicine and biology.
    Lowe KC
    Vox Sang; 1991; 60(3):129-40. PubMed ID: 1862635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Red cell substitutes: hemoglobin solution or fluorocarbon?
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Rice CL; Moss GS
    J Trauma; 1982 Sep; 22(9):736-40. PubMed ID: 7120525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorocarbon-based oxygen carriers: new orientations.
    Riess JG
    Artif Organs; 1991 Oct; 15(5):408-13. PubMed ID: 1741687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxygen delivery from fluorocarbon emulsions--aspects of convective and diffusive transport.
    Faithfull NS
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):797-804. PubMed ID: 1391514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparative study of the effects of hemodilution with dextran and fluorocarbon emulsion on the changes in blood viscosity and collateral flow during myocardial ischemia].
    Ma XL; Zhao RR; Zang YM; Wang FZ
    Yao Xue Xue Bao; 1987 Sep; 22(9):641-4. PubMed ID: 2451396
    [No Abstract]   [Full Text] [Related]  

  • 37. [Successive replacement of fatal blood loss in dogs with polyglucin and perfluorocarbon emulsion].
    Akhsianov UU; Afonin NI
    Biull Eksp Biol Med; 1984 Aug; 98(8):160-2. PubMed ID: 6205706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical potential of intravenously administered perfluorocarbons.
    Habler O; Kleen M; Messmer K
    Acta Anaesthesiol Scand Suppl; 1997; 111():256-8. PubMed ID: 9421036
    [No Abstract]   [Full Text] [Related]  

  • 39. Current status of erythrocyte substitutes.
    Biro GP
    Can Med Assoc J; 1983 Aug; 129(3):237-44. PubMed ID: 6344974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability and stabilization of fluorocarbon emulsions destined for injection.
    Riess JG; Postel M
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):819-30. PubMed ID: 1391516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.